Archive for February, 2020

  • The first patient included in Japan in Isofol’s Phase 3 AGENT study

    GOTHENBURG, Sweden, February 18 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first…

  • Empowered patient podcast

    Our CEO, Dr. Ulf Jungnelius, was featured on Karen Jagoda’s empowered patient podcast to discuss colorectal cancer and how our…